<DOC>
	<DOC>NCT00103922</DOC>
	<brief_summary>This study was designed to determine if the investigational drug is effective and safe in individuals with COPD (chronic pulmonary disease)</brief_summary>
	<brief_title>Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease)</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases, Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Cilomilast</mesh_term>
	<criteria>Inclusion criteria: Diagnosis of COPD and a history of cigarette smoking. Exclusion criteria: Significant heart or lung disease not associated with COPD. Significant stomach or intestinal disease.</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>smokers cough</keyword>
</DOC>